Cytek Biosciences
CTKB
#5857
Rank
โ‚น71.15 B
Marketcap
โ‚น552.39
Share price
0.46%
Change (1 day)
-30.02%
Change (1 year)

Revenue for Cytek Biosciences (CTKB)

Revenue in 2024 (TTM): โ‚น16.78 Billion

According to Cytek Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚น17.12 Billion. In 2023 the company made a revenue of โ‚น16.06 Billion an increase over the revenue in the year 2022 that were of โ‚น13.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytek Biosciences from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น16.78 B4.47%
2023 โ‚น16.06 B18.37%
2022 โ‚น13.57 B42.53%
2021 โ‚น9.52 B40.26%
2020 โ‚น6.78 B